Direct-to-Abdomen chemo trial offers hope for tough cancers
NCT ID NCT01061515
Summary
This early-stage study is testing whether delivering one chemotherapy drug directly into the abdomen, while giving two others by mouth and vein, is safe and tolerable for people with advanced abdominal cancer from colorectal or appendix tumors. The treatment is given after surgery to remove visible cancer. Researchers want to find the highest dose patients can handle while monitoring how the cancer responds over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.